Drug Type Small molecule drug |
Synonyms ISM024-148, ISM5043, MEN-2312 + [1] |
Target |
Mechanism KAT6A inhibitors(lysine acetyltransferase 6A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
ER-positive/HER2-negative Breast Cancer | Phase 1 | - | - | |
Solid tumor | Phase 1 | - | - | |
Breast Cancer | Preclinical | US | 04 Jan 2024 |